BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guglielmelli P, Loscocco GG, Mannarelli C, Rossi E, Mannelli F, Ramundo F, Coltro G, Betti S, Maccari C, Ceglie S, Chiusolo P, Paoli C, Barbui T, Tefferi A, De Stefano V, Vannucchi AM. JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis. Blood Cancer J 2021;11:199. [PMID: 34897288 DOI: 10.1038/s41408-021-00581-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Mora B, Passamonti F. SOHO State of the Art Updates and Next Questions | Polycythemia Vera: Is It Time to Rethink Treatment? Clin Lymphoma Myeloma Leuk 2023;23:79-85. [PMID: 36566109 DOI: 10.1016/j.clml.2022.11.011] [Reference Citation Analysis]
2 Guglielmelli P, Maccari C, Sordi B, Balliu M, Atanasio A, Mannarelli C, Capecchi G, Sestini I, Coltro G, Loscocco GG, Rotunno G, Angori E, Borri FC, Tefferi A, Vannucchi AM. Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis. Blood Cancer J 2023;13:21. [PMID: 36710362 DOI: 10.1038/s41408-023-00786-x] [Reference Citation Analysis]
3 Thiele J, Kvasnicka HM, Orazi A, Gianelli U, Gangat N, Vannucchi AM, Barbui T, Arber DA, Tefferi A. The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms. Am J Hematol 2023;98:166-79. [PMID: 36200127 DOI: 10.1002/ajh.26751] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Vannucchi AM, Guglielmelli P. Molecular prognostication in Ph-negative MPNs in 2022. Hematology Am Soc Hematol Educ Program 2022;2022:225-34. [PMID: 36485130 DOI: 10.1182/hematology.2022000339] [Reference Citation Analysis]
5 Rolles B, Mullally A. Molecular Pathogenesis of Myeloproliferative Neoplasms. Curr Hematol Malig Rep 2022;17:319-29. [PMID: 36336766 DOI: 10.1007/s11899-022-00685-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang Z, Liu W, Wang D, Yang E, Li Y, Li Y, Sun Y, Wang M, Lv Y, Hu X. TET2 Mutation May Be More Valuable in Predicting Thrombosis in ET Patients Compared to PV Patients: A Preliminary Report. J Clin Med 2022;11. [PMID: 36431092 DOI: 10.3390/jcm11226615] [Reference Citation Analysis]
7 Kanduła Z, Janowski M, Więckowska B, Paczkowska E, Lewandowski K. JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. J Cancer Res Clin Oncol 2022. [PMID: 36242602 DOI: 10.1007/s00432-022-04327-0] [Reference Citation Analysis]
8 Lim HY, Ho P. Thrombosis Risk Assessment in Myeloproliferative Neoplasm-Is There a Role for Viscoelastic Testing? Semin Thromb Hemost 2022. [PMID: 36055269 DOI: 10.1055/s-0042-1753483] [Reference Citation Analysis]
9 Mora B, Guglielmelli P, Kuykendall A, Rumi E, Maffioli M, Palandri F, De Stefano V, Caramella M, Salmoiraghi S, Kiladjian JJ, Gotlib J, Iurlo A, Cervantes F, Ruggeri M, Silver RT, Albano F, Benevolo G, Ross DM, Della Porta MG, Devos T, Rotunno G, Komrokji RS, Casetti IC, Merli M, Brociner M, Caramazza D, Auteri G, Barbui T, Cattaneo D, Bertù L, Arcaini L, Vannucchi AM, Passamonti F. Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients. Leukemia 2022. [PMID: 36042316 DOI: 10.1038/s41375-022-01673-3] [Reference Citation Analysis]
10 Barbui T. Clonal hematopoiesis and inflammation: a link with thrombosis and malignancy. Bleed Thromb Vascul Biol 2022;1. [DOI: 10.4081/btvb.2022.38] [Reference Citation Analysis]
11 Leiva O, Hobbs G, Ravid K, Libby P. Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol 2022;4:166-82. [PMID: 35818539 DOI: 10.1016/j.jaccao.2022.04.002] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Krečak I, Celić-bunikić S, Skelin M, Lucijanić M, Verstovsek S, Kušec R. Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate. Ann Hematol. [DOI: 10.1007/s00277-022-04839-2] [Reference Citation Analysis]